GILEAD SCIENCES INC 4
4 · GILEAD SCIENCES INC · Filed Nov 22, 2016
Insider Transaction Report
Form 4
MADIGAN JOHN W
Director
Transactions
- Sale
Common Stock
2016-11-18$74.86/sh−105,000$7,860,058→ 16,761 total - Exercise/Conversion
Common Stock
2016-11-18$20.70/sh+105,000$2,174,025→ 121,761 total - Exercise/Conversion
Non-qualified Stock Option (Right to Buy)
2016-11-18−105,000→ 0 totalExercise: $20.70Exp: 2017-05-09→ Common Stock (105,000 underlying)
Footnotes (2)
- [F1]Options vested in full on May 9, 2007, the date of grant.
- [F2]Sale prices reported for the transactions reported here range from $74.55 to $75.18. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.